ABBOTT ASIA INVESTMENTS LIMITED

Company number 05556000

Date	Type	Description	View / Download
20 Nov 2024	CS01	Confirmation statement made on 16 November 2024 with no updates	(3 pages)
23 Jul 2024	AA	Full accounts made up to 31 December 2023	(28 pages)
23 Nov 2023	CS01	Confirmation statement made on 21 November 2023 with no updates	(3 pages)
25 Oct 2023	AP01	Appointment of Mrs Alison Elizabeth Davies as a director on 15 October 2023	(2 pages)
25 Oct 2023	TM01	Termination of appointment of John Arthur Mccoy as a director on 15 October 2023	(1 page)
24 Aug 2023	AA	Full accounts made up to 31 December 2022	(22 pages)
18 Apr 2023	AD02	Register inspection address has been changed from 7 Albemarle Street London W1S 4HQ England to Abbott Uk, Sovereign House 1-2 Bingham Road Sittingbourne Kent ME10 3SU	(1 page)
18 Apr 2023	AD03	Register(s) moved to registered inspection location 7 Albemarle Street London W1S 4HQ	(1 page)
16 Dec 2022	SH01	Statement of capital following an allotment of shares on 15 December 2022 GBP 1,358,256,035	(3 pages)
15 Dec 2022	SH19	Statement of capital on 15 December 2022 GBP 110,035	(3 pages)
15 Dec 2022	SH20	Statement by Directors	(3 pages)
15 Dec 2022	CAP-SS	Solvency Statement dated 15/12/22	(3 pages)
15 Dec 2022	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital	(3 pages)
28 Nov 2022	CS01	Confirmation statement made on 21 November 2022 with no updates	(3 pages)
31 Oct 2022	AD02	Register inspection address has been changed from C/O Abbott Sovereign House 1-2 Bingham Road Sittingbourne Kent ME10 3SU United Kingdom to 7 Albemarle Street London W1S 4HQ	(1 page)
09 Aug 2022	AA	Full accounts made up to 31 December 2021	(22 pages)
22 Nov 2021	CS01	Confirmation statement made on 21 November 2021 with no updates	(3 pages)
01 Oct 2021	AA	Full accounts made up to 31 December 2020	(23 pages)
23 Mar 2021	AP01	Appointment of John Arthur Mccoy as a director on 22 March 2021	(2 pages)
23 Mar 2021	TM01	Termination of appointment of Karen Marie Peterson as a director on 22 March 2021	(1 page)
23 Dec 2020	CS01	Confirmation statement made on 21 November 2020 with no updates	(3 pages)
23 Dec 2020	PSC07	Cessation of Abbott Laboratories Inc. as a person with significant control on 16 April 2016	(1 page)
07 Oct 2020	AA	Full accounts made up to 31 December 2019	(22 pages)
06 May 2020	AP01	Appointment of Mr Michael Robert Kendall Clayton as a director on 23 March 2020	(2 pages)
05 May 2020	TM01	Termination of appointment of Georgios Mountrichas as a director on 23 March 2020	(1 page)